🧩
Free audit · No signup
Tool Sprawl Risk Audit — Diagnostics Labs
Find out how much spreadsheet and SaaS sprawl is costing Diagnostics Labs — and where a purpose-built internal tool pays off.
Signs of tool sprawl in Diagnostics Labs
- Test turnaround time is the operational and clinical KPI but the bottleneck moves around — phlebotomy, transport, accessioning, instrument, or result-release — and the operating model rarely sees the whole chain.
- Reimbursement is under sustained pressure — PAMA, payer down-coding, and Z-code requirements all shrink the realized price per test.
- LIS-to-EHR integration is brittle and expensive; every new client integration is a custom project that delays revenue and complicates support.
- Lab automation, robotics, and middleware investment is ongoing but the business case rarely reflects the labor, error-rate, and turnaround uplift in an integrated way.
Section 1 of 4 · Source of Truth0/8 answered
Source of Truth
Whether your operational data lives in one place or is scattered across tools.
Ran the numbers? Let’s act on them.
Send us the result and the constraint behind it. We’ll scope the diagnostic, sprint, or build that fixes what the score reveals.